Contemporary use of devices in chronic heart failure in the Netherlands

Autor: Michiel J. Nagelsmit, Anne G. Raafs, Ayten Erol-Yilmaz, Hans‐Peter Brunner‐LaRocca, Remko M. Oortman, Gerard C.M. Linssen, Jacobus Plomp, Jeroen P.P. Smits, Jasper J. Brugts, Arno W. Hoes
Přispěvatelé: Cardiology, Cardiologie, RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9)
Rok vydání: 2020
Předmět:
Male
lcsh:Diseases of the circulatory (Cardiovascular) system
implantable cardioverter defibrillator
task-force
HF
genetic structures
medicine.medical_treatment
primary prevention
cardiac resynchronization therapy
heart failure
030204 cardiovascular system & hematology
GUIDELINES
THERAPY
Ventricular Function
Left
0302 clinical medicine
Original Research Articles
follow-up
Original Research Article
030212 general & internal medicine
Netherlands
Ejection fraction
real-world heart failure management
Middle Aged
Implantable cardioverter-defibrillator
cardiovascular system
Female
Real‐world heart failure management
reduced ejection fraction
Cardiology and Cardiovascular Medicine
therapeutics
circulatory and respiratory physiology
medicine.medical_specialty
SEX-DIFFERENCES
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
Cardiac resynchronization therapy
survival
03 medical and health sciences
Device therapy
Internal medicine
medicine
Humans
cardiovascular diseases
Aged
business.industry
Stroke Volume
Odds ratio
Guideline
electrical device therapy
medicine.disease
Icd therapy
Cross-Sectional Studies
lcsh:RC666-701
Heart failure
business
Zdroj: ESC heart failure, 7(4), 1771-1780. The Heart Failure Association of the European Society of Cardiology
Esc heart failure, 7(4), 1771-1780. John Wiley & Sons Inc.
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 4, Pp 1771-1780 (2020)
ISSN: 2055-5822
Popis: Aims Despite previous surveys regarding device implantation rates in heart failure (HF), insight into the real-world management with devices is scarce. Therefore, we investigated device implantation rates in HF with reduced left ventricular ejection fraction (LVEF) in 34 Dutch centres.Methods and results A cross-sectional outpatient registry was conducted in 6666 patients with LVEF < 50% and with information about device implantation available [74 (66-81) years of age; 64% male]. Patients were classified into conventional pacemakers (PM, n = 562), implantable cardioverter defibrillators (ICD, n = 1165), and cardiac resynchronization therapy with defibrillator function (CRT-D, n = 885) or pacemaker function only (CRT-P, n = 248), or no device (n = 3806). Centres were divided into ICD-implanting and CRT-implanting and referral centres. Overall, 17.5% had an ICD, 13.3% CRT-D, 3.7% CRT-P, and 8.4% PM. Of those with LVEF
Databáze: OpenAIRE
Externí odkaz: